Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 155

1.

Relationship between intra-operative vein graft treatment with DuraGraft® or saline and clinical outcomes after coronary artery bypass grafting.

Haime M, McLean RR, Kurgansky KE, Emmert MY, Kosik N, Nelson C, Gaziano MJ, Cho K, Gagnon DR.

Expert Rev Cardiovasc Ther. 2018 Oct 4:1-8. doi: 10.1080/14779072.2018.1532289. [Epub ahead of print]

PMID:
30285502
2.

Epicardial Left Atrial Appendage Exclusion Reduces Blood Pressure in Patients With Atrial Fibrillation and Hypertension.

Turagam MK, Vuddanda V, Verberkmoes N, Ohtsuka T, Akca F, Atkins D, Bommana S, Emmert MY, Gopinathannair R, Dunnington G, Rasekh A, Cheng J, Salzberg S, Natale A, Cox J, Lakkireddy DR.

J Am Coll Cardiol. 2018 Sep 18;72(12):1346-1353. doi: 10.1016/j.jacc.2018.06.066.

PMID:
30213326
3.

Development of a Novel Human Cell-Derived Tissue-Engineered Heart Valve for Transcatheter Aortic Valve Replacement: an In Vitro and In Vivo Feasibility Study.

Lintas V, Fioretta ES, Motta SE, Dijkman PE, Pensalfini M, Mazza E, Caliskan E, Rodriguez H, Lipiski M, Sauer M, Cesarovic N, Hoerstrup SP, Emmert MY.

J Cardiovasc Transl Res. 2018 Aug 13. doi: 10.1007/s12265-018-9821-1. [Epub ahead of print]

PMID:
30105605
4.

Cellular self-assembly into 3D microtissues enhances the angiogenic activity and functional neovascularization capacity of human cardiopoietic stem cells.

Wolint P, Bopp A, Woloszyk A, Tian Y, Evrova O, Hilbe M, Giovanoli P, Calcagni M, Hoerstrup SP, Buschmann J, Emmert MY.

Angiogenesis. 2018 Jul 16. doi: 10.1007/s10456-018-9635-4. [Epub ahead of print]

PMID:
30014173
5.

Christiaan Barnard-The Surgeon Who Dared.

Emmert MY.

Eur Heart J. 2018 Jun 14;39(23):2133-2134. doi: 10.1093/eurheartj/ehy265. No abstract available.

PMID:
29905820
6.

Approximation of the Incidence of Myocarditis by Systematic Screening With Cardiac Magnetic Resonance Imaging.

Patriki D, Gresser E, Manka R, Emmert MY, Lüscher TF, Heidecker B.

JACC Heart Fail. 2018 Jul;6(7):573-579. doi: 10.1016/j.jchf.2018.03.002. Epub 2018 Jun 6.

PMID:
29885953
7.

The effect of oxygen in Sirt3-mediated myocardial protection: a proof-of-concept study in cultured cardiomyoblasts.

Diehl P, Gaul DS, Sogl J, Flierl U, Henstridge D, Pahla J, Bugger H, Emmert MY, Ruschitzka F, Bode C, Lüscher TF, Moser M, Matter CM, Peter K, Winnik S.

J Thromb Thrombolysis. 2018 Jul;46(1):102-112. doi: 10.1007/s11239-018-1677-3.

PMID:
29774488
8.

Computational modeling guides tissue-engineered heart valve design for long-term in vivo performance in a translational sheep model.

Emmert MY, Schmitt BA, Loerakker S, Sanders B, Spriestersbach H, Fioretta ES, Bruder L, Brakmann K, Motta SE, Lintas V, Dijkman PE, Frese L, Berger F, Baaijens FPT, Hoerstrup SP.

Sci Transl Med. 2018 May 9;10(440). pii: eaan4587. doi: 10.1126/scitranslmed.aan4587.

PMID:
29743347
9.

DuraGraft vascular conduit preservation solution in patients undergoing coronary artery bypass grafting: rationale and design of a within-patient randomised multicentre trial.

Ben Ali W, Voisine P, Olsen PS, Jeanmart H, Noiseux N, Goeken T, Satishchandran V, Cademartiri F, Cutter G, Veerasingam D, Brown C, Emmert MY, Perrault LP.

Open Heart. 2018 Apr 13;5(1):e000780. doi: 10.1136/openhrt-2018-000780. eCollection 2018.

10.

Cardiovascular tissue engineering: From basic science to clinical application.

Fioretta ES, von Boehmer L, Motta SE, Lintas V, Hoerstrup SP, Emmert MY.

Exp Gerontol. 2018 Mar 28. pii: S0531-5565(18)30066-4. doi: 10.1016/j.exger.2018.03.022. [Epub ahead of print] Review.

PMID:
29604404
11.

Development of an Off-the-Shelf Tissue-Engineered Sinus Valve for Transcatheter Pulmonary Valve Replacement: a Proof-of-Concept Study.

Motta SE, Fioretta ES, Dijkman PE, Lintas V, Behr L, Hoerstrup SP, Emmert MY.

J Cardiovasc Transl Res. 2018 Jun;11(3):182-191. doi: 10.1007/s12265-018-9800-6. Epub 2018 Mar 20.

PMID:
29560553
12.

Surgical device-enabled epicardial LAA closure to achieve safe, complete, and durable LAA occlusion.

Caliskan E, Cox JL, Falk V, Salzberg SP, Emmert MY.

Nat Rev Cardiol. 2018 Feb 13;15(3):191. doi: 10.1038/nrcardio.2018.8. No abstract available.

PMID:
29434359
13.

Translational cardiac stem cell therapy: advancing from first-generation to next-generation cell types.

Cambria E, Pasqualini FS, Wolint P, Günter J, Steiger J, Bopp A, Hoerstrup SP, Emmert MY.

NPJ Regen Med. 2017 Jun 13;2:17. doi: 10.1038/s41536-017-0024-1. eCollection 2017. Review.

14.

Off-the-shelf tissue engineered heart valves for in situ regeneration: current state, challenges and future directions.

Motta SE, Lintas V, Fioretta ES, Hoerstrup SP, Emmert MY.

Expert Rev Med Devices. 2018 Jan;15(1):35-45. doi: 10.1080/17434440.2018.1419865. Epub 2017 Dec 28. Review.

PMID:
29257706
15.

Fifty years of heart transplantation: A journey of courage, innovation and persistence, celebrated in Cape Town.

Emmert MY.

Eur Heart J. 2017 Dec 7;38(46):3405. doi: 10.1093/eurheartj/ehx696. No abstract available.

PMID:
29232447
16.

Surgical techniques for left atrial appendage exclusion.

Salzberg SP, Emmert MY, Caliskan E.

Herzschrittmacherther Elektrophysiol. 2017 Dec;28(4):360-365. doi: 10.1007/s00399-017-0532-0. Epub 2017 Nov 17. Review.

PMID:
29150698
17.

Challenges in translating tissue engineered heart valves into clinical practice.

Emmert MY, Hoerstrup SP.

Eur Heart J. 2017 Mar 1;38(9):619-621. doi: 10.1093/eurheartj/ehx075. No abstract available.

PMID:
29121258
18.

Next generation heart valve substitutes.

Emmert MY, Hoerstrup SP.

Eur Heart J. 2017 Mar 1;38(9):617-618. doi: 10.1093/eurheartj/ehx074. No abstract available.

PMID:
29121257
19.

Managing the Left Atrial Appendage.

Emmert MY.

Eur Heart J. 2017 May 21;38(20):1537-1540. doi: 10.1093/eurheartj/ehx237. No abstract available.

PMID:
29121173
20.

Epicardial left ventricular leads via minimally invasive technique: a role of steroid eluting leads.

Caliskan E, Fischer F, Schoenrath F, Emmert MY, Maisano F, Falk V, Starck CT, Holubec T.

J Cardiothorac Surg. 2017 Nov 8;12(1):95. doi: 10.1186/s13019-017-0659-4.

21.

Cell-based cardiac regeneration.

Emmert MY.

Eur Heart J. 2017 Apr 14;38(15):1095-1098. doi: 10.1093/eurheartj/ehx152. No abstract available.

PMID:
29117292
22.

Impact of Left Atrial Appendage Exclusion on Cardiovascular Outcomes in Patients With Atrial Fibrillation Undergoing Coronary Artery Bypass Grafting-The Surgeon's Comment.

Caliskan E, Salzberg SP, Emmert MY.

Am J Cardiol. 2018 Jan 1;121(1):142. doi: 10.1016/j.amjcard.2017.09.017. Epub 2017 Oct 12. No abstract available.

PMID:
29103602
23.

Monitoring and manipulating cellular crosstalk during kidney fibrosis inside a 3D in vitro co-culture.

Nugraha B, Mohr MA, Ponti A, Emmert MY, Weibel F, Hoerstrup SP, Moll S, Certa U, Prunotto M, Pantazis P.

Sci Rep. 2017 Nov 3;7(1):14490. doi: 10.1038/s41598-017-12683-y.

24.

Tissue engineered regenerating blood vessels: Restoring the body's circulation with regenerating blood vessels-a reality?

Emmert MY.

Eur Heart J. 2017 Nov 1;38(41):3045-3048. doi: 10.1093/eurheartj/ehx524. No abstract available.

PMID:
29099989
25.

Regenerative transcatheter valves.

Emmert MY, Hoerstrup SP.

Eur Heart J. 2017 Sep 21;38(36):2710-2713. doi: 10.1093/eurheartj/ehx476. No abstract available.

PMID:
29044390
26.

Epicardial left atrial appendage AtriClip occlusion reduces the incidence of stroke in patients with atrial fibrillation undergoing cardiac surgery.

Caliskan E, Sahin A, Yilmaz M, Seifert B, Hinzpeter R, Alkadhi H, Cox JL, Holubec T, Reser D, Falk V, Grünenfelder J, Genoni M, Maisano F, Salzberg SP, Emmert MY.

Europace. 2018 Jul 1;20(7):e105-e114. doi: 10.1093/europace/eux211.

PMID:
29016813
27.

Sternal Anomalies in Asymptomatic Patients after Median Sternotomy and Potential Influencing Factors.

Rodriguez Cetina Biefer H, Sündermann SH, Alkadhi H, Genoni M, Maisano F, Emmert MY, Plass A.

Thorac Cardiovasc Surg. 2018 Sep;66(6):517-522. doi: 10.1055/s-0037-1607217. Epub 2017 Oct 7.

PMID:
28987082
28.

Intrinsic remote conditioning of the myocardium as a comprehensive cardiac response to ischemia and reperfusion.

Pavo N, Lukovic D, Zlabinger K, Lorant D, Goliasch G, Winkler J, Pils D, Auer K, Ankersmit HJ, Giricz Z, Sárközy M, Jakab A, Garamvölgyi R, Emmert MY, Hoerstrup SP, Hausenloy DJ, Ferdinandy P, Maurer G, Gyöngyösi M.

Oncotarget. 2017 Jun 12;8(40):67227-67240. doi: 10.18632/oncotarget.18438. eCollection 2017 Sep 15.

29.

Gender differences in fibrosis remodeling in patients with long-standing persistent atrial fibrillation.

Li Z, Wang Z, Yin Z, Zhang Y, Xue X, Han J, Zhu Y, Zhang J, Emmert MY, Wang H.

Oncotarget. 2017 Mar 17;8(32):53714-53729. doi: 10.18632/oncotarget.16342. eCollection 2017 Aug 8.

30.

CABG in the era of modern PCI.

Emmert MY.

Eur Heart J. 2017 Jul 7;38(26):2029-2032. doi: 10.1093/eurheartj/ehx328. No abstract available.

PMID:
28838059
31.

40 Years on.

Emmert MY, Templin C.

Eur Heart J. 2017 Jul 21;38(28):2158-2160. doi: 10.1093/eurheartj/ehx333. No abstract available.

PMID:
28838046
32.

Clot-entrapped blood cells in synergy with human mesenchymal stem cells create a pro-angiogenic healing response.

Burkhardt MA, Gerber I, Moshfegh C, Lucas MS, Waser J, Emmert MY, Hoerstrup SP, Schlottig F, Vogel V.

Biomater Sci. 2017 Sep 26;5(10):2009-2023. doi: 10.1039/c7bm00276a.

PMID:
28809406
33.

Interventional and surgical occlusion of the left atrial appendage.

Caliskan E, Cox JL, Holmes DR Jr, Meier B, Lakkireddy DR, Falk V, Salzberg SP, Emmert MY.

Nat Rev Cardiol. 2017 Dec;14(12):727-743. doi: 10.1038/nrcardio.2017.107. Epub 2017 Aug 10. Review.

PMID:
28795688
34.

JetValve: Rapid manufacturing of biohybrid scaffolds for biomimetic heart valve replacement.

Capulli AK, Emmert MY, Pasqualini FS, Kehl D, Caliskan E, Lind JU, Sheehy SP, Park SJ, Ahn S, Weber B, Goss JA, Hoerstrup SP, Parker KK.

Biomaterials. 2017 Jul;133:229-241. doi: 10.1016/j.biomaterials.2017.04.033. Epub 2017 Apr 18.

35.

Reply to Sadeque et al.

Holubec T, Sahin A, Emmert MY.

Eur J Cardiothorac Surg. 2017 Aug 1;52(2):397-398. doi: 10.1093/ejcts/ezx080. No abstract available.

PMID:
28379319
36.

Translational Challenges in Cardiovascular Tissue Engineering.

Emmert MY, Fioretta ES, Hoerstrup SP.

J Cardiovasc Transl Res. 2017 Apr;10(2):139-149. doi: 10.1007/s12265-017-9728-2. Epub 2017 Mar 9. Review.

PMID:
28281240
37.

Sequential activation of different pathway networks in ischemia-affected and non-affected myocardium, inducing intrinsic remote conditioning to prevent left ventricular remodeling.

Pavo N, Lukovic D, Zlabinger K, Zimba A, Lorant D, Goliasch G, Winkler J, Pils D, Auer K, Jan Ankersmit H, Giricz Z, Baranyai T, Sárközy M, Jakab A, Garamvölgyi R, Emmert MY, Hoerstrup SP, Hausenloy DJ, Ferdinandy P, Maurer G, Gyöngyösi M.

Sci Rep. 2017 Mar 7;7:43958. doi: 10.1038/srep43958.

38.

In situ heart valve tissue engineering using a bioresorbable elastomeric implant - From material design to 12 months follow-up in sheep.

Kluin J, Talacua H, Smits AI, Emmert MY, Brugmans MC, Fioretta ES, Dijkman PE, Söntjens SH, Duijvelshoff R, Dekker S, Janssen-van den Broek MW, Lintas V, Vink A, Hoerstrup SP, Janssen HM, Dankers PY, Baaijens FP, Bouten CV.

Biomaterials. 2017 May;125:101-117. doi: 10.1016/j.biomaterials.2017.02.007. Epub 2017 Feb 8.

39.

Safety and efficacy of cardiopoietic stem cells in the treatment of post-infarction left-ventricular dysfunction - From cardioprotection to functional repair in a translational pig infarction model.

Emmert MY, Wolint P, Jakab A, Sheehy SP, Pasqualini FS, Nguyen TDL, Hilbe M, Seifert B, Weber B, Brokopp CE, Macejovska D, Caliskan E, von Eckardstein A, Schwartlander R, Vogel V, Falk V, Parker KK, Gyöngyösi M, Hoerstrup SP.

Biomaterials. 2017 Apr;122:48-62. doi: 10.1016/j.biomaterials.2016.11.029. Epub 2016 Nov 23.

PMID:
28107664
40.

Increased Proangiogenic Activity of Mobilized CD34+ Progenitor Cells of Patients With Acute ST-Segment-Elevation Myocardial Infarction: Role of Differential MicroRNA-378 Expression.

Templin C, Volkmann J, Emmert MY, Mocharla P, Müller M, Kraenkel N, Ghadri JR, Meyer M, Styp-Rekowska B, Briand S, Klingenberg R, Jaguszewski M, Matter CM, Djonov V, Mach F, Windecker S, Hoerstrup SP, Thum T, Lüscher TF, Landmesser U.

Arterioscler Thromb Vasc Biol. 2017 Feb;37(2):341-349. doi: 10.1161/ATVBAHA.116.308695. Epub 2016 Dec 29.

41.

Nogo-A regulates vascular network architecture in the postnatal brain.

Wälchli T, Ulmann-Schuler A, Hintermüller C, Meyer E, Stampanoni M, Carmeliet P, Emmert MY, Bozinov O, Regli L, Schwab ME, Vogel J, Hoerstrup SP.

J Cereb Blood Flow Metab. 2017 Feb;37(2):614-631. doi: 10.1177/0271678X16675182. Epub 2016 Nov 13.

42.

Cardiac Regenerative Medicine: The Potential of a New Generation of Stem Cells.

Cambria E, Steiger J, Günter J, Bopp A, Wolint P, Hoerstrup SP, Emmert MY.

Transfus Med Hemother. 2016 Jul;43(4):275-281. Epub 2016 Jul 26. Review.

43.

Organ Chips: Quality Assurance Systems in Regenerative Medicine.

Pasqualini FS, Emmert MY, Parker KK, Hoerstrup SP.

Clin Pharmacol Ther. 2017 Jan;101(1):31-34. doi: 10.1002/cpt.527. Epub 2016 Nov 21.

44.

The future of heart valve replacement: recent developments and translational challenges for heart valve tissue engineering.

Fioretta ES, Dijkman PE, Emmert MY, Hoerstrup SP.

J Tissue Eng Regen Med. 2018 Jan;12(1):e323-e335. doi: 10.1002/term.2326. Epub 2017 Mar 29. Review.

PMID:
27696730
45.

Percutaneous repair of the tricuspid valve using a novel cinching device: acute and chronic experience in a preclinical large animal model.

Taramasso M, Latib A, Denti P, Nietlispach F, Lynn K, Cesarovic N, Addis A, Emmert MY, Guidotti A, Vanermen H, Maisano F.

EuroIntervention. 2016 Sep 18;12(7):918-25. doi: 10.4244/EIJV12I7A150.

46.

Effect of Bone Marrow-Derived Mononuclear Cell Treatment, Early or Late After Acute Myocardial Infarction: Twelve Months CMR and Long-Term Clinical Results.

Sürder D, Manka R, Moccetti T, Lo Cicero V, Emmert MY, Klersy C, Soncin S, Turchetto L, Radrizzani M, Zuber M, Windecker S, Moschovitis A, Bühler I, Kozerke S, Erne P, Lüscher TF, Corti R.

Circ Res. 2016 Jul 22;119(3):481-90. doi: 10.1161/CIRCRESAHA.116.308639. Epub 2016 Jun 6.

PMID:
27267068
47.

Long-term follow-up after aortic root replacement with the Shelhigh® biological valved conduit: a word of caution!

Sahin A, Müggler O, Sromicki J, Caliskan E, Reser D, Emmert MY, Alkadhi H, Maisano F, Falk V, Holubec T.

Eur J Cardiothorac Surg. 2016 Dec;50(6):1172-1178. doi: 10.1093/ejcts/ezw167. Epub 2016 May 26.

PMID:
27229673
48.

Microtissues in Cardiovascular Medicine: Regenerative Potential Based on a 3D Microenvironment.

Günter J, Wolint P, Bopp A, Steiger J, Cambria E, Hoerstrup SP, Emmert MY.

Stem Cells Int. 2016;2016:9098523. doi: 10.1155/2016/9098523. Epub 2016 Mar 17. Review.

49.

Tissue engineered heart valves: moving towards clinical translation.

Emmert MY, Hoerstrup SP.

Expert Rev Med Devices. 2016 May;13(5):417-9. doi: 10.1586/17434440.2016.1171709. Epub 2016 Apr 7. No abstract available.

PMID:
27052826
50.

Synergistic interactions of blood-borne immune cells, fibroblasts and extracellular matrix drive repair in an in vitro peri-implant wound healing model.

Burkhardt MA, Waser J, Milleret V, Gerber I, Emmert MY, Foolen J, Hoerstrup SP, Schlottig F, Vogel V.

Sci Rep. 2016 Feb 17;6:21071. doi: 10.1038/srep21071.

Supplemental Content

Loading ...
Support Center